---
title: "Definium Therapeutics issues options for 30,330 shares to new hires under inducement plan"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293249267.md"
description: "Definium Therapeutics issued inducement stock options for 30,330 common shares to two new non-executive hires. The grant date is July 20, 2026, with an exercise price based on the closing share value. The awards vest over four years: 25% after the first year, with the remainder distributed in monthly installments over the subsequent three years."
datetime: "2026-07-20T20:01:32.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293249267.md)
  - [en](https://longbridge.com/en/news/293249267.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293249267.md)
---

# Definium Therapeutics issues options for 30,330 shares to new hires under inducement plan

-   Definium Therapeutics issued inducement stock options covering 30,330 common shares to two newly hired non-executive employees. \* Options carry an effective grant date of July 20, 2026. \* Exercise price set at the closing price of Definium’s common shares on the grant date. \* Award vests over four years: 25% after year one, remainder in monthly installments over the next three years. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Definium Therapeutics Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202607201601BIZWIRE\_USPR\_\_\_\_\_20260720\_BW055756) on July 20, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [DFTX.US](https://longbridge.com/en/quote/DFTX.US.md)

## Related News & Research

- [Is Definium Therapeutics (DFTX) Expensive As New GAD Study Sharpens Its Late Stage Case?](https://longbridge.com/en/news/293649367.md)
- [Definium Therapeutics Sets $805 Million Public Offering at $34; Underwriting Agreement Signed](https://longbridge.com/en/news/290742592.md)
- [08:46 ETHTX Research Examines RWA and DeFi: Two Separate Tracks Converging into One Financial Loop](https://longbridge.com/en/news/293935104.md)
- [Chainlink price prediction 2026-2032: A strong buy sentiment for LINK?](https://longbridge.com/en/news/293873202.md)
- [Roundtable’s AI/DeFi Platform Unveiled to London Press, Media Executives to Help Restore Classic Journalism | RTB Stock News](https://longbridge.com/en/news/293523037.md)